The research, published today (10 June) in the journal Nature Cell Biology shows that the controlled release of a specific molecule, called miR-675, slows down growth of the placenta before birth.
RNA molecules are best known as the intermediary between the cell's DNA and the making of proteins necessary for cell function. However, there are also many RNA molecules with functions other than encoding proteins. Babraham Institute scientists are involved in researching the role of these noncoding RNAs, including microRNAs (a type of short noncoding RNA molecule) which are important for regulating cell development and function.
The noncoding RNA H19 is one of the most abundant RNA molecules found in mammals but until now its function was unknown. This study, in collaboration with academics in France, the USA and Belgium, is the first to show that a microRNA called miR-675 is 'cut out' and released from the longer H19 RNA in the placenta and that this limits placental growth.
Dr Andrew Keniry from the Babraham Institute who is lead author explained, "The function of the H19 noncoding RNA has proven elusive for many years. We have shown that it appears to act as an inert molecule used to store the functional miR-675 until it is required by the cell to slow placental growth. This is a very exciting finding and reveals a new purpose for noncoding RNA. It is also intriguing that the release of miR-675 is controlled by a stress-response protein, suggesting this may be a mechanism the developing embryo can use to regulate its growth in the womb."
Professor Wolf Reik, senior author of the paper and a Group Leader at the Babraham Institute, which receives strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC) said, "It's interesting to see how the growth of the placenta can be regulated in this flexible way before birth. Perhaps there are environmental signals and influences from the mother's diet on the growth of the placenta and hence the healthy baby. It's also fascinating how an RNA that is so abundant in the cell can be a quick-release reservoir of a growth regulating small RNA, and this may be generally important for how cell growth is regulated by the environment."
The Babraham Institute undertakes world-leading life sciences research to generate new knowledge of biological mechanisms underpinning ageing, development and the maintenance of health. Professor Michael Wakelam, Director of the Babraham Institute, commented, "This research gives a new insight into how placental growth can be regulated, which is important for the health of the baby and in later life, supporting BBSRC's mission to drive advances in fundamental bioscience for better health and wellbeing." In addition to the BBSRC, this research was supported by the Wellcome Trust, the MRC, the EU, the Cambridge Commonwealth Trust and the Centre for Trophoblast Research.
Dr Anja Drozd | EurekAlert!
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Earth Sciences
05.12.2016 | Physics and Astronomy
05.12.2016 | Life Sciences